Case Report: Grade 4 pneumonitis occurred after thoracic radiotherapy and dacomitinib in a patient with lung adenocarcinoma
Osimertinib combined with chest radiotherapy has a high incidence of pneumonia, dacomitinib is widely used in clinical practice, but there are no studies reporting the pulmonary safety of dacomitinib in combinating with radiotherapy. Here we report a case of radiation pneumonitis occurring by dacomi...
Saved in:
| Main Authors: | Ailing Liu, Junxu Wen, Kaikai Zhao, Liyang Jiang, Xiangjiao Meng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1436134/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-world data of dacomitinib as first-line treatment for patients with EGFR-mutant non-small-cell lung cancer
by: Ji Eun Shin, et al.
Published: (2025-02-01) -
Lung Adenocarcinoma With Initially Co‐Occurring EGFR and BRAF Double Mutation: A Case Report and Literature Review
by: Lu Wang, et al.
Published: (2025-03-01) -
Impact of pneumonitis from radiotherapy combined with immune checkpoint inhibitors therapy on tumor progression and survival in patients with non-small cell lung cancer
by: Ziwei Wang, et al.
Published: (2025-05-01) -
A Case Report of Lung Adenocarcinoma with EGFR G719A Mutation
and LMNA-NTRK1 Fusion
by: Shiqi SONG, et al.
Published: (2025-01-01) -
Evaluation of the optimal timing of radiotherapy in EGFR-Mutant oligometastatic NSCLC through a retrospective analysis of treatment sequences and survival outcomes
by: Meng Zhang, et al.
Published: (2025-08-01)